This was the stock's second consecutive day of losses.

The Zacks Medical - Outpatient and Home Healthcare industry has been witnessing a rapid shift toward digital healthcare ...

Of the 30 companies included in the list, 24 firms saw their stock prices rise, four saw their share prices decline, and two saw their stock prices remain flat.

Quest Diagnostics is expected to unveil its second-quarter results later this month, and analysts expect a single-digit ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks ...

BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and ...

While Quest Diagnostics has outshined the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously ...

Quest Diagnostics Incorporated (NYSE:DGX), a prominent provider of diagnostic testing and information services, has hit a record-breaking share price of $180.11, pushing the company’s market ...

Robert W. Baird analyst Eric Coldwell maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $797.00. The company’s shares opened today at ...

Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands ...